The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea.
about
Breast cancer multigene testing trends and impact on chemotherapy use.Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.Spotlight on the utility of the Oncotype DX® breast cancer assay.Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer.
P2860
The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The clinical impact of 21-gene ...... early breast cancer in Korea.
@ast
The clinical impact of 21-gene ...... early breast cancer in Korea.
@en
type
label
The clinical impact of 21-gene ...... early breast cancer in Korea.
@ast
The clinical impact of 21-gene ...... early breast cancer in Korea.
@en
prefLabel
The clinical impact of 21-gene ...... early breast cancer in Korea.
@ast
The clinical impact of 21-gene ...... early breast cancer in Korea.
@en
P2093
P2860
P356
P1476
The clinical impact of 21-gene ...... e early breast cancer in Korea
@en
P2093
Eun Sook Lee
Heeseung Park
Hyun Joo Shin
Jeong Eon Lee
Jong Won Lee
Jongjin Kim
Ku Sang Kim
Moo Hyun Lee
Wonshik Han
P2860
P304
P356
10.4143/CRT.2013.223
P50
P577
2014-09-11T00:00:00Z